Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancersElke Jäger, Alexander Knuth, Antje Neumann et al.|Proceedings of the National Academy of Sciences|2000Cited by 426
Monitoring CD8 T cell responses to NY-ESO-1: Correlation of humoral and cellular immune responsesElke Jäger, Alexander Knuth, Yasuhiro Nagata et al.|Proceedings of the National Academy of Sciences|2000Cited by 398
Safety and efficacy of AMG 820, an anti-colony-stimulating factor 1 receptor antibody, in combination with pembrolizumab in adults with advanced solid tumorsAlbiruni RA Razak, Kyriakos P. Papadopoulos, James M. Cleary et al.|Journal for ImmunoTherapy of Cancer|2020Cited by 117